Limited use of leveraged and leveraged inverse ETFs serve an important part of our family's investment portfolio; the risks associated with these products -- the impact of volatility on returns, tracking errors associated with holding leveraged ETPs longer than 1 day, etc. are *very* clearly spelled out in each ETP's prospectus, with most going so far as to provide tables to illustrate such risks.
Given the caution already urged by brokers and the clarity and concision with which ETP providers communicate risks to potential investors, there's no reasonable need to require tests, net worth requirements or any other restrictions; this is particularly true when one compares the risk of such investment instruments with the idiosyncratic risks associated with holding stocks, sector ETFs and other common investments.
Simply put, there's no problem that requires solving in this instance and by adding additional restrictions to these products, FINRA will undermine the free market with potentially disastrous consequences (reductions in trading volume resulting in liquidity issues, pricing issues; brokers dropping these products entirely because they don't want to incur the costs associated with supporting restrictions imposed by FINRA) for common retail investors like my husband and I.
Rather than complex products themselves, *it's additional restrictions floated by FINRA in the 22-08 notice that are putting our family's financial security at risk*.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Sarah Costa Comment On Regulatory Notice 22-08
Limited use of leveraged and leveraged inverse ETFs serve an important part of our family's investment portfolio; the risks associated with these products -- the impact of volatility on returns, tracking errors associated with holding leveraged ETPs longer than 1 day, etc. are *very* clearly spelled out in each ETP's prospectus, with most going so far as to provide tables to illustrate such risks.
Given the caution already urged by brokers and the clarity and concision with which ETP providers communicate risks to potential investors, there's no reasonable need to require tests, net worth requirements or any other restrictions; this is particularly true when one compares the risk of such investment instruments with the idiosyncratic risks associated with holding stocks, sector ETFs and other common investments.
Simply put, there's no problem that requires solving in this instance and by adding additional restrictions to these products, FINRA will undermine the free market with potentially disastrous consequences (reductions in trading volume resulting in liquidity issues, pricing issues; brokers dropping these products entirely because they don't want to incur the costs associated with supporting restrictions imposed by FINRA) for common retail investors like my husband and I.
Rather than complex products themselves, *it's additional restrictions floated by FINRA in the 22-08 notice that are putting our family's financial security at risk*.